FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears LifeSignals ECG Remote Patch Platform

FDA gives 510(k) clearance to LifeSignals Groups LifeSignals ECH remote monitoring patch platform to detect common cardiac arrhythmias.

Human Drugs

FDA Will Meet with Petros on Stendra Labeling

FDA will meet with Petros over proposed labeling changes for the companys Stendra erectile dysfunction medicine.

Human Drugs

FDA Approves Sol-Gels Twyneo Acne Treatment

FDA approves Sol-Gel Technologies acne medication Twyneo that uses a patented technology to stabilize one of the active ingredients.

Medical Devices

Evren Breakthrough on Earbud PTSD Therapy

FDA grants Evren Technologies a breakthrough device designation for its Phoenix earbud device and its use in treating post-traumatic stress disorder.

Human Drugs

Incyte BLA for Retifanlimab Turned Down by FDA

FDA issues Incyte a complete response letter on its BLA for retifanlimab, an intravenous PD-1 inhibitor for treating certain adult patients with local...

Federal Register

Cell Tissue Panel to Discuss Toxicity Risks

Federal Register notice: FDA announces a 9/2-3 Cellular, Tissue and Gene Therapies Advisory Committee meeting.

Federal Register

Gloves Remain Class 1; 510(k) Required

Federal Register notice: FDA rescinds a 1/15 notice that identified seven types of reserved Class 1 devices that HHS had determined no longer require ...

Human Drugs

FDA Complete Response on Iterum NDA

FDA issues Iterum Therapeutics a complete response letter on its NDA for sulopenem etzadroxil/probenecid, indicated for treating treat multi-drug resi...

Federal Register

Comments Extended on Powered Patient Transport

Federal Register notice: FDA extends the comment period for a 6/15 notice on: Exemption from Premarket Notification: Powered Patient Transports.

Federal Register

Patient Advocates Sought for FDA Collaboration

Federal Register notice: FDA and the Clinical Trials Transformation Initiative request applications for patient advocates interested in participating ...